Clinical Trial Update: Dose Escalation/Dose Expansion Study of YBL-006 in Patients With Advanced Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 dose-escalation and dose-expansion study of YBL-006 in patients with advanced solid tumors being conducted, status currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• YBL-006

Snippet

Sponsor: Y Biologics Inc. | Conditions: Advanced Solid Tumors | Phase 1, Phase 2 | Status: UNKNOWN